Open Nav

Alkahest, Inc.

  • Michael Byrnes, Alkahest, Inc.

Increasing investor awareness

  • Date:Wednesday, October 17
  • Time:11:00 AM - 11:15 AM
  • Room:Elizabethan C
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:Alkahest’s mission is to enrich the health and vitality of humankind through the discovery and development of innovative medicines for the treatment of age-related diseases.
  • Company Website:
  • Company HQ City:San Carlos
  • Company HQ Country:United States
  • Company HQ State:California                  
  • CEO/Top Company Official:Karoly Nikolich
  • Year Founded:2014
  • Main Therapeutic Focus:CNS/Neurological
  • Lead Product in Development :ALK 6019 - Human Plasma Fraction
  • Development Phase of Primary Product:Phase II
  • Total Amount Raised to Date, In All Rounds:Less than $50MM
Michael Byrnes
Alkahest, Inc.